Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shaw

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Clinical Chemistry|August 1, 1984
Development of a stable reference material for prostatic acid phosphataseP H Duncan, R L Van Etten, M L MacNeil, et al.
Cell|January 15, 1998
Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasionL M Shaw, I Rabinovitz, H H Wang, et al.
Clinical Therapeutics|November 24, 1999
Current opinions on therapeutic drug monitoring of immunosuppressive drugsL M Shaw, D W Holt, P Keown, et al.
Cell Motility and the Cytoskeleton|January 1, 1993
Fimbrin localized to an insoluble cytoskeletal fraction is constitutively phosphorylated on its headpiece domain in adherent macrophagesJ M Messier, L M Shaw, M Chafel, et al.
Diabetes Care|December 1, 1994
Diabetic nephropathy and microalbuminuria in the community. The South Auckland Diabetes SurveyD Simmons, L M Shaw, D J Scott, et al.
Clinical Chemistry|September 1, 1981
Immunochemical evaluation of the organ specificity of prostatic acid phosphataseL M Shaw, N Yang, J J Brooks, et al.
Aviation, Space, and Environmental Medicine|April 1, 1993
Unregulated self-medication in an ambulatory surgery populationR J Bagshaw, L M Shaw, T August, et al.
Clinical Chemistry|February 1, 1976
Effect of halothane anesthesia on muscle, liver, thyroid, and adrenal-function tests in manR E Johnstone, E M Kennell, W Brummund, et al.
Urology|December 1, 1986
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markersB Seamonds, N Yang, K Anderson, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1993
Bypassing the first-pass effect for the therapeutic use of cannabinoidsR D Mattes, L M Shaw, J Edling-Owens, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Clinical Chemistry|August 1, 1984
Development of a stable reference material for prostatic acid phosphataseP H Duncan, R L Van Etten, M L MacNeil, et al.
Cell|January 15, 1998
Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasionL M Shaw, I Rabinovitz, H H Wang, et al.
Clinical Therapeutics|November 24, 1999
Current opinions on therapeutic drug monitoring of immunosuppressive drugsL M Shaw, D W Holt, P Keown, et al.
Cell Motility and the Cytoskeleton|January 1, 1993
Fimbrin localized to an insoluble cytoskeletal fraction is constitutively phosphorylated on its headpiece domain in adherent macrophagesJ M Messier, L M Shaw, M Chafel, et al.
Diabetes Care|December 1, 1994
Diabetic nephropathy and microalbuminuria in the community. The South Auckland Diabetes SurveyD Simmons, L M Shaw, D J Scott, et al.
Clinical Chemistry|September 1, 1981
Immunochemical evaluation of the organ specificity of prostatic acid phosphataseL M Shaw, N Yang, J J Brooks, et al.
Aviation, Space, and Environmental Medicine|April 1, 1993
Unregulated self-medication in an ambulatory surgery populationR J Bagshaw, L M Shaw, T August, et al.
Clinical Chemistry|February 1, 1976
Effect of halothane anesthesia on muscle, liver, thyroid, and adrenal-function tests in manR E Johnstone, E M Kennell, W Brummund, et al.
Urology|December 1, 1986
Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markersB Seamonds, N Yang, K Anderson, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1993
Bypassing the first-pass effect for the therapeutic use of cannabinoidsR D Mattes, L M Shaw, J Edling-Owens, et al.
Pageof 20